Literature DB >> 28223906

Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes.

Christy B Williamson1, Cathleen M Burns1, Crystal M Gossard1, Jessica M Pizano1, Keren E Dolan1, Heather J Finley1, Margaret G Gasta1, Emily C Parker1, Elizabeth A Lipski1.   

Abstract

This article series provides a literature review of the disease-specific probiotic strains, associated with cardiometabolic diseases and fatigue syndromes, studied in published clinical trials in humans and animals. This is not an exhaustive review. The table design allows for quick access to supportive data and will be helpful as a guide for both researchers and clinicians. The goal of the probiotics and disease series is to provide clinically useful tools. The first article (part 1) focused on mental health and neurological conditions and the second article (part 2) explored cultured and fermented foods that are commonly available in the United States. This third article (part 3) explores the relationship between bacterial strains and 2 of the most prevalent diseases we have in modern society: cardiometabolic disease and fatigue syndromes. Future articles will review conditions related to respiratory, ear, nose, and throat infections and infectious diseases; autoimmunity and dermatological conditions; cancer; and gastrointestinal and genitourinary, followed by an article focused on probiotic supplements. This literature review is specific to disease condition, probiotic classification, and individual strain.

Entities:  

Year:  2017        PMID: 28223906      PMCID: PMC5312743     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  63 in total

1.  Formation of oligosaccharides in skim milk fermented with mixed dahi cultures, Lactococcus lactis ssp diacetylactis and probiotic strains of lactobacilli.

Authors:  Hariom Yadav; Shalini Jain; Pushpalata Ravindra Sinha
Journal:  J Dairy Res       Date:  2007-02-12       Impact factor: 1.904

2.  Probiotics: definition, sources, selection, and uses.

Authors:  Mary Ellen Sanders
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

3.  Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases.

Authors:  L Agerholm-Larsen; A Raben; N Haulrik; A S Hansen; M Manders; A Astrup
Journal:  Eur J Clin Nutr       Date:  2000-04       Impact factor: 4.016

4.  Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial.

Authors:  Y Kadooka; M Sato; K Imaizumi; A Ogawa; K Ikuyama; Y Akai; M Okano; M Kagoshima; T Tsuchida
Journal:  Eur J Clin Nutr       Date:  2010-03-10       Impact factor: 4.016

5.  Deconjugation of bile acids by intestinal lactobacilli.

Authors:  S E Gilliland; M L Speck
Journal:  Appl Environ Microbiol       Date:  1977-01       Impact factor: 4.792

Review 6.  Probiotic use in clinical practice: what are the risks?

Authors:  Robert J Boyle; Roy M Robins-Browne; Mimi L K Tang
Journal:  Am J Clin Nutr       Date:  2006-06       Impact factor: 7.045

7.  Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice.

Authors:  M P Taranto; M Medici; G Perdigon; A P Ruiz Holgado; G F Valdez
Journal:  J Dairy Sci       Date:  2000-03       Impact factor: 4.034

8.  Effects of four Bifidobacteria on obesity in high-fat diet induced rats.

Authors:  Ya-Ni Yin; Qiong-Fen Yu; Nian Fu; Xiao-Wei Liu; Fang-Gen Lu
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

9.  A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome.

Authors:  A Venket Rao; Alison C Bested; Tracey M Beaulne; Martin A Katzman; Christina Iorio; John M Berardi; Alan C Logan
Journal:  Gut Pathog       Date:  2009-03-19       Impact factor: 4.181

10.  Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome.

Authors:  Asa Sullivan; Carl E Nord; Birgitta Evengård
Journal:  Nutr J       Date:  2009-01-26       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.